采购
产品
供应
企业
学习及工作经历
2008.09-2013.06 兰州大学 化学化工学院 博士
2013.07-2015.07 新加坡南洋理工大学 化学与生物工程学院 Research Fellow
2015.07-至今 西南大学 材料与能源学部 副教授,硕士生导师
主要研究领域、方向
主要研究领域为纳米生物材料,开展了智能型药物递送系统、高灵敏分子荧光探针和靶向小分子药物的合成及其性能研究。
研究成果(200字以内)
截止目前,在Chemical Communication,Acta Biomaterialia,Biomacromolecules,Nanoscale等国际著名刊物上发表SCI论文60余篇,研究论文累计被他人正面引用达1000余次,目前个人H影响因子20,申请国家发明专利10余项,授权1项。成果曾获2014年度甘肃省高校科技进步奖一等奖(本人排名第三),担任重庆功能材料学会理事。
荣誉&获奖
承担科研、教改和教学质量工程项目
1、GSH/pH响应型星形聚合物前药的设计、构建及靶向抗肿瘤研究,国家自然科学基金(51703187),2018.01-2020.12,22万,项目负责人
2、激活型单分子胶束药物载体的设计及抗肿瘤性能研究,重庆市基础研究与前沿探索项目(cstc2018jcyjAX0104),2018.07-2021.06,10万,项目负责人
3. 星形聚合物荧光探针的设计、合成及在肿瘤早期诊断中的应用,四川省应用基础研究计划(面上项目,2018JY0392),2018.07-2020.06,10万,项目负责人
4、pH敏感型星形单分子聚合物的构建及其在肿瘤诊断与治疗中的应用,重庆市基础与前沿研究计划项目(cstc2016jcyjA0078),2016.07-2019.06,5万,项目负责人
5、智能型小分子药物传递系统的设计、合成及其在癌症治疗中的应用研究,中央高校基本科研业务费一般项目(XDJK2016C004),2016.01-2017.12,5万,项目负责人
6、西南大学人才引进基金(SWU115058),2016.01-2018.12,20万,项目负责人
1. Xiaoqian Ma, Xiaoxiao Shi, Shuang Bai, Jianjian Zhang, Meili Hou, Tian Zhang, Bao-sheng Li, Peng Xue, Yuejun Kang*, Zhigang Xu*, Water-soluble Fluorescent Unimolecular Micelles: Ultra-small size, tunable fluorescence emission from visible to NIR region and enhanced biocompatibility for in vitro and in vivo bioimaging, Chem. Commun., 2018, 54, 6252-6255. (IF2017 = 6.290, Front cover)
2. Meili Hou, Yong-E Gao, Xiaoxiao Shi, Shuang Bai, Xiaoqian Ma, Baosheng Li, Bo Xiao, Peng Xue, Yuejun Kang*, ZhigangXu*, Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy. Acta Biomaterialia, 2018, 77, 228-239 (IF2017 = 6.383)
3. Shuang Bai, Xiaoli Zhang, Xiaoqian Ma, Jiuncun Chen, Qiubing Chen, Xiaoxiao Shi, Meili Hou, Peng Xue, Yuejun Kang*, Zhigang Xu*, Acid-active supramolecular anticancer nanoparticles based on cyclodextrin polyrotaxanes damaging both mitochondria and nuclei of tumor cells. Biomaterials Science, 2018, 6, 3126-3138. (IF2017 = 5.831, Front cover).
4. Xiaoxiao Shi, Shuang Bai, Cangjie Yang, Xiaoqian Ma, Meili Hou, Jiucun Chen, Peng Xue, Chang Ming Li, Yuejun Kang*, Zhigang Xu*, Improving the carrier stability and drug loading of unimolecular micelle-based nanotherapeutics for acid-activated drug delivery and enhanced antitumor therapy. Journal of Materials Chemistry B, 2018, 6, 5549-5561. (IF2017 = 4.776, Back cover)
5. Shuang Bai, Meili Hou, Xiaoxiao Shi, Jiuncun Chen, Xiaoqian Ma, Yong-E Gao, Yajun Wang, Peng Xue, Yuejun Kang*, Zhigang Xu*, Reduction-active polymeric prodrug micelles based on α-cyclodextrin polyrotaxanes for triggered drug release and enhanced cancer therapy, Carbohydrate Polymers, 2018, 193, 153-162. (IF2017 = 5.158)
6. Shuang Bai, Yong-E Gao, Xiaoqian Ma, Xiaoxiao Shi, Meili Hou, Peng Xue*, Yuejun Kang*, Zhigang Xu*, Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery, Carbohydrate Polymers, Carbohydrate Polymers, 2018, 182, 235-244. (IF2017 = 5.158)
7. Xiaoxiao Shi, Xiaoqian Ma, Meili Hou, Yong-E Gao, Shuang Bai, Bo Xiao, Peng Xue, Yuejun Kang, Zhigang Xu*, Chang Ming Li, pH-responsive unimolecular micelles based on amphiphilic star-like copolymers with high drug loading for effective drug delivery and cellular imaging, Journal of Materials Chemistry B, 2017, 5, 6847-6859. (IF2017 = 4.776)
8. Xiaoxiao Shi, Meili Hou, Shuang Bai, Xiaoqian Ma, Yong-E Gao, Bo Xiao, Peng Xue, Yuejun Kang*, Zhigang Xu*, Chang Ming Li, Acid-Activatable Theranostic Unimolecular Micelles Composed of Amphiphilic Star-like Polymeric Prodrug with High Drug Loading for Enhanced Cancer Therapy, Molecular Pharmaceutics, 2017, 14, 4032-4041. (IF2017 = 4.556)
9. Meili Hou, Peng Xue, Yong-E Gao, Xiaoqian Ma, Shuang Bai, Yuejun Kang*, Zhigang Xu*, Gemcitabine–camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics, Biomaterials Science , 2017, 5, 1889-1897. (IF2017 = 5.831).
10. Zhigang Xu, Shiying Liu, Hui Liu, Cangjie Yang, Yuejun Kang and Mingfeng Wang*, Unimolecular micelles of amphiphilic cyclodextrin-core star-like block copolymers for anticancer drug delivery, Chemical Communication, 2015, 51, 15768-15771. (IF2017 = 6.290)
。。。